A new viral vector manufacturing facility being built in the Westmead precinct is set to change the treatment landscape for patients with genetic diseases, cancers and viral infections, enabling gene therapies to be trialled and delivered sooner.
Viral vectors are a key component of many cell and gene therapies. The technology uses viruses that are harmless to humans to carry... read more.
You are viewing this article on the Kids Research website. To see read the full article, please see the Sydney Children's Hospitals Network website.
Read full article